Genix Pharmaceuticals Corporation (TSXV:GENX)

Genix Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Cash & Equivalents	0.04	0.01	0.01	0.01	0.14
Cash & Short-Term Investments	0.04	0.01	0.01	0.01	0.14
Cash Growth	279.69%	-1.30%	25.51%	-93.32%	-80.07%
Other Receivables	0	0.01	0	0.02	0
Receivables	0	0.01	0	0.02	0
Inventory	-	-	0.16	0.17	0
Prepaid Expenses	0.01	0.02	0.04	0.04	0.04
Total Current Assets	0.05	0.04	0.22	0.24	0.19
Property, Plant & Equipment	-	-	-	0	0.03
Other Intangible Assets	0	0.01	0.01	4.01	4.55
Total Assets	0.05	0.05	0.22	4.25	4.77
Accounts Payable	0.16	0.15	0.25	0.21	0.01
Accrued Expenses	0.02	0.02	0.02	0.02	0.03
Short-Term Debt	1.04	0.82	0.51	0.18	0.02
Current Portion of Leases	-	-	-	0	0.02
Other Current Liabilities	0.25	0.24	0.58	0.64	0.66
Total Current Liabilities	1.47	1.23	1.36	1.05	0.74
Long-Term Leases	-	-	-	-	0.01
Total Liabilities	1.47	1.23	1.36	1.05	0.76
Common Stock	9.76	9.7	9.7	9.7	9.7
Retained Earnings	-12.54	-12.2	-12.13	-7.74	-6.66
Comprehensive Income & Other	1.36	1.32	1.29	1.23	0.97
Shareholders' Equity	-1.42	-1.18	-1.14	3.2	4.01
Total Liabilities & Equity	0.05	0.05	0.22	4.25	4.77
Total Debt	1.04	0.82	0.51	0.18	0.05
Net Cash (Debt)	-1	-0.8	-0.5	-0.17	0.09
Net Cash Growth	-	-	-	-	-86.81%
Net Cash Per Share	-0.02	-0.01	-0.01	-0.00	0.00
Filing Date Shares Outstanding	61.22	59.22	59.22	59.22	59.22
Total Common Shares Outstanding	61.22	59.22	59.22	59.22	59.22
Working Capital	-1.42	-1.19	-1.15	-0.81	-0.56
Book Value Per Share	-0.02	-0.02	-0.02	0.05	0.07
Tangible Book Value	-1.42	-1.19	-1.15	-0.81	-0.53
Tangible Book Value Per Share	-0.02	-0.02	-0.02	-0.01	-0.01

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.